Last updated: May 29, 2026

Application No. 17/992,470

METHODS FOR THE PREVENTION OR TREATMENT OF ANTHRAX INFECTION

Final Rejection

Filed

Nov 22, 2022

Priority

Nov 24, 2021 — provisional 63/283,068

Examiner

LIU, SUE XU

Art Unit

1616

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Cumberland Pharmaceuticals Inc.

OA Round

2 (Final)

This examiner grants 21% of cases after interview

— +15.4% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 228 resolved cases, 2023–2026

Examiner Intelligence

LIU, SUE XU View full profile →

Grants only 21% of cases

Career Allowance Rate

47 granted / 228 resolved

-39.4% vs TC avg

Strong +15% interview lift

Without

With

+15.4%

Interview Lift

resolved cases with interview

Typical timeline

4y 5m

Avg Prosecution

21 currently pending

Career history

278

Total Applications

across all art units

Statute-Specific Performance

§101

1.3%

-38.7% vs TC avg

§103

64.1%

+24.1% vs TC avg

§102

4.6%

-35.4% vs TC avg

§112

9.0%

-31.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 228 resolved cases

Prosecution Timeline

Nov 22, 2022

Application Filed

May 07, 2025

Non-Final Rejection mailed

Aug 07, 2025

Response Filed

Sep 09, 2025

Final Rejection mailed

Apr 21, 2026

Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

17/606,262

Patent 12616677

INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

4y 6m to grant Granted May 05, 2026

18/245,971

Patent 12616206

GRAPHENE-SILVER NANOCOMPOSITES AND USES FOR SAME AS AN ANTIMICROBIAL COMPOSITION

3y 1m to grant Granted May 05, 2026

18/638,945

Patent 12616198

LIPO-CHITOOLIGOSACCHARIDE COMPOSITIONS FOR ENHANCING PLANT GROWTH

2y 0m to grant Granted May 05, 2026

17/462,664

Patent 12610946

FORMULATIONS FOR DECONTAMINATING A SURFACE

4y 8m to grant Granted Apr 28, 2026

17/690,520

Patent 12611374

DERMATOLOGICAL COLLAR FOR NON-HUMAN ANIMALS

4y 1m to grant Granted Apr 28, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4

Expected OA Rounds

21%

Grant Probability

36%

With Interview (+15.4%)

4y 5m (~11m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 228 resolved cases by this examiner. Grant probability derived from career allowance rate.